Frélii, Inc. Share Price

FRLI

US3570511010

Advanced Medical Equipment & Technology

Delayed OTC Markets Other stock markets 15:43:42 01/07/2026 BST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-99.00%

16/12/20	Frélii, Inc. cancelled the acquisition of 25% shares of Genecor AI Inc. from Helix Investment Partners LLC.	CI
08/01/20	Frélii, Inc. announced that it has received $0.203 million in funding	CI

Frelii, Inc. provides Web-based nutrition and fitness programs based on usersâ€™ genetic data. The Company provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies usersâ€™ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Companyâ€™s site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The Company provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. It provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume

Delayed Quote OTC Markets

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
FRLI Stock

Google lets you customize your preferred sources.

Choose MarketScreener

Market Cap	11.76M 10.29M 9.49M 8.77M 16.63M 1.12B 16.91M 113M 44.53M 553M 44.17M 43.21M 1.9B	P/E 2017	21.4x	P/E 2018	-12.5x
Enterprise Value	11.7M 10.24M 9.44M 8.72M 16.55M 1.12B 16.83M 113M 44.31M 550M 43.95M 42.99M 1.89B	EV / Sales 2017	-	EV / Sales 2018	2,167,635,443x
Free-Float	100%	Yield 2017 *	-	Yield 2018	-

16/12/20	Frélii, Inc. cancelled the acquisition of 25% shares of Genecor AI Inc. from Helix Investment Partners LLC.	CI
08/01/20	Frélii, Inc. announced that it has received $0.203 million in funding	CI
22/12/19	Frélii, Inc. entered into share purchase agreement to acquire 25% shares of Genecor AI Inc. for $0.94 million from Helix Investment Partners LLC.	CI
14/11/19	Frélii, Inc. announced that it has received $0.154 million in funding	CI
14/11/19	Frélii, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	CI
14/08/19	Frélii, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	CI
16/07/19	Frelii, Inc. Announces Resignation of Leslie Norris as Chief Operating Officer; Opens Its First Wholly Owned Subsidiary, Frelii Canada Inc. in Mississauga, Ontario, Canada	CI
10/06/19	Frélii, Inc. Inks Agreement with Orn Health Inc. to Support Healthcare Franchisee Partners Incorporating Pharmacogentics Into Patient Treatment	CI
22/05/19	Frelii Inc. Announces Executive Changes	CI
20/05/19	Frélii, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	CI
01/05/19	Frélii, Inc. Signs Contract and Licensing Agreement with Optivida Health	CI
16/04/19	Frélii, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	CI
12/04/19	Frélii, Inc. Announces Address Change	CI

1 month	0		0
Current year	0		0
1 year	0		0
3 years	0		0.04
5 years	0		0.04
10 years	0		10

Manager	Title	Age	Since
Ian Jenkins CEO	Chief Executive Officer	42	04/04/2017
Sandeep Uppal ADM	Chief Administrative Officer	-	21/05/2019
Jayson Uffens CTO	Chief Tech/Sci/R&D Officer	51	14/05/2018

Director	Title	Age	Since
Ian Jenkins BRD	Director/Board Member	42	04/04/2017
Tarek Mango BRD	Director/Board Member	55	31/12/2017
Hans Jenkins BRD	Director/Board Member	49	26/03/2018

Frélii, Inc. Share Price

Stocks

FRLI

US3570511010

Advanced Medical Equipment & Technology

Valuation: Frélii, Inc.

Chart: Frélii, Inc.

Latest news : Frélii, Inc.

Course Extremes

Managers and Directors: Frélii, Inc.

Medical Software & Technology Services

Financials

Company Profile

Quotes

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
FRÉLII, INC.	0.00%	0.00%	-	-	58
VEEVA SYSTEMS INC.	+0.10%	-1.09%	-32.57%	-4.96%	30.82B
PRO MEDICUS LIMITED	-6.34%	-4.30%	-37.37%	+213.11%	15.26B
SECTRA AB	-0.77%	-4.53%	-20.85%	+62.11%	5.68B
HEARTFLOW, INC.	-4.04%	-1.77%	-	-	2.39B
OMNICELL, INC.	-1.96%	-1.19%	+50.15%	-38.21%	2.07B
GENERATE BIOMEDICINES, INC.	-6.55%	-14.07%	-	-	2.02B
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	-0.98%	-12.26%	-30.95%	-	1.1B
ARBUTUS BIOPHARMA CORPORATION	-7.68%	-4.53%	+44.66%	+109.96%	1.02B
RAYSEARCH LABORATORIES AB	+0.60%	+0.69%	-33.62%	+306.25%	825M
Average	-2.73%	-1.18%	-8.65%	+108.04%	6.12B
Weighted average by Cap.	-2.17%	-0.77%	-28.27%	+67.13%

	2017	2018
Net sales	-	0.04 0.03 0.03 0.03 0.05 3.43 0.05 0.35 0.14 1.69 0.13 0.13 5.81
Net income	595K 521K 480K 444K 842K 56.79M 856K 5.74M 2.25M 27.98M 2.24M 2.19M 96.19M	-5.55M -4.85M -4.48M -4.14M -7.85M -529M -7.98M -53.5M -21.01M -261M -20.84M -20.38M -896M
Net Debt	37.06K 32.42K 29.9K 27.62K 52.41K 3.53M 53.29K 357K 140K 1.74M 139K 136K 5.99M	-58.56K -51.22K -47.24K -43.64K -82.8K -5.58M -84.19K -564K -222K -2.75M -220K -215K -9.46M